Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/21308
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorPASSOS, Talita Rocha-
dc.contributor.authorSANTOS, Fabiana Silva-
dc.contributor.authorMARTINS, Maria Cleusa-
dc.contributor.authorPINTO, Vanusa Barbosa-
dc.contributor.authorCARRILHO, Flair Jose-
dc.contributor.authorONO, Suzane Kioko-
dc.date.accessioned2017-08-17T19:16:22Z-
dc.date.available2017-08-17T19:16:22Z-
dc.date.issued2017-
dc.identifier.citationREVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.63, n.5, p.401-406, 2017-
dc.identifier.issn0104-4230-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/21308-
dc.description.abstractSince 2010, the Clinical Gastroenterology and Hepatology Division of the Central Institute of Hospital das Clinicas of the University of Sao Paulo Medical School (HC-FMUSP, in the Portuguese acronym) has been developing specialized electives assistance activities in the Outpatient Specialty Clinic, Secondary Level, in Sao Paulo NGA-63 Varzea do Carmo. The objective of this study was to analyze the pharmacotherapeutic profile of patients. This is a cross-sectional and retrospective study in which patients were seen at the Hepatology sector and the results were submitted to descriptive statistics. During the study period, 492 patients were treated at the clinic, with a mean age of 58.9 years and frequency of 61.2% female and 74.8% living in Sao Paulo. This population was served by various other medical specialties (cardiology and endocrine among others) and the major liver diagnoses were: chronic hepatitis B and C and fatty liver. Comorbidities were also identified, such as diabetes, hypertension and dyslipidemia. Most patients took their medication in the Basic Health Units. We found that 30% of patients use of more than five medications and the most prescribed were omeprazole 208 (42.3%), metformin 132 (26.8%) and losartan 80 (16.3%). Because it is an adult/elderly population, with several comorbidities and polymedication, it is important to be aware of the rational use of medication. The multidisciplinary team is important in applying correct conducts for the safe use of medicines, to reduce the burden on health spending and improving the quality of life of patients.-
dc.language.isoeng-
dc.publisherASSOC MEDICA BRASILEIRA-
dc.relation.ispartofRevista da Associacao Medica Brasileira-
dc.rightsopenAccess-
dc.subjecthepatitis-
dc.subjectdrug-
dc.subjectpolypharmacy-
dc.subjectambulatory care-
dc.subjecthematology-
dc.subjectomeprazole-
dc.subject.otherfatty liver-disease-
dc.subject.otherchronic hepatitis-c-
dc.subject.othernonalcoholic steatohepatitis-
dc.subject.otherinactive hbv-
dc.subject.othermanagement-
dc.subject.otherresistance-
dc.subject.othercarriers-
dc.titleClinical pharmacology profile of care in Hepatology clinic-
dc.typearticle-
dc.rights.holderCopyright ASSOC MEDICA BRASILEIRA-
dc.identifier.doi10.1590/1806-9282.63.05.401-
dc.identifier.pmid28724036-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage401-
hcfmusp.description.endpage406-
hcfmusp.description.issue5-
hcfmusp.description.volume63-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-85024398056-
hcfmusp.origem.idWOS:000405950400005-
hcfmusp.origem.idSCIELO:S0104-42302017000500401-
hcfmusp.publisher.citySAO PAULO-
hcfmusp.publisher.countryBRAZIL-
hcfmusp.relation.referenceAbbasinazari M, 2014, IRAN J PHARM RES, V13, P1221-
hcfmusp.relation.referenceAlves MLF, 2015, REV MED MINAS GERAIS, V25, P469-
hcfmusp.relation.referenceArmstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717-
hcfmusp.relation.referenceBjerrum L, 1999, BRIT J GEN PRACT, V49, P195-
hcfmusp.relation.referenceBookman ID, 2006, LIVER INT, V26, P566, DOI 10.1111/j.1478-3231.2006.01256.x-
hcfmusp.relation.referenceBrouwer WP, 2016, CLIN GASTROENTEROL H, V14, P1481, DOI 10.1016/j.cgh.2016.01.019-
hcfmusp.relation.referenceBrunt EM, 2004, SEMIN LIVER DIS, V24, P3-
hcfmusp.relation.referenceChalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001-
hcfmusp.relation.referenceCotta LSF, 2011, INFARMA, V23, P32-
hcfmusp.relation.referenceD'Amico Gennaro, 2012, Hepatology, V55, P642, DOI 10.1002/hep.24695-
hcfmusp.relation.referenceHwang Y, 2015, KOREAN J INTERN MED, V30, P792, DOI 10.3904/kjim.2015.30.6.792-
hcfmusp.relation.referenceIida Vivian Helena, 2005, J. Bras. Patol. Med. Lab., V41, P29, DOI 10.1590/S1676-24442005000100008-
hcfmusp.relation.referenceInvernizzi F, 2016, LIVER INT, V36, P100, DOI 10.1111/liv.13006-
hcfmusp.relation.referenceJimenez-Perez M, 2016, WORLD J GASTROENTERO, V22, P6573, DOI 10.3748/wjg.v22.i29.6573-
hcfmusp.relation.referenceBrasil. Ministerio da Saude, 2013, PROT CLIN DIR TER TR-
hcfmusp.relation.referenceBrasil. Ministerio da Saude, 2015, PROT CLIN DIR TER TR-
hcfmusp.relation.referenceOliveira JEP, 2015, DIRETRIZES SOC BRASI, P1-
hcfmusp.relation.referenceSchwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050-
hcfmusp.relation.referenceSerra CG, 2010, CIENC SAUDE COLETIVA, V15, P3579, DOI 10.1590/S1413-81232010000900033-
hcfmusp.relation.referenceSociedade Brasileira de Cardiologia Sociedade Brasileira de Hipertensao Sociedade Brasileira de Nefrologia, 2007, ARQ BRAS CARDIOL, V89, pe24-
hcfmusp.relation.referenceXavier HT, 2013, ARQ BRAS CARDIOL S1, V101, P1, DOI 10.5935/ABC.2013S010-
hcfmusp.relation.referenceYu ML, 2016, EXP THER MED, V12, P1103, DOI 10.3892/etm.2016.3444-
hcfmusp.relation.referenceZipprich A, 2012, Z GASTROENTEROL, V50, P996, DOI 10.1055/s-0031-1299446-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus0-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MGT
Departamento de Gastroenterologia - FM/MGT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/07
LIM/07 - Laboratório de Gastroenterologia Clínica e Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_PASSOS_Clinical_pharmacology_profile_of_care_in_Hepatology_clinic_2017.PDFpublishedVersion (English)147.85 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.